About Us                                                                                  Scientific Publications

Technology and Product                                                  Intellectual Property

Core Technologies

Product Pipeline                                                                   Partnerships

Rheumatoid Arthritis

Crohn's Disease                                                                     Mission

Advanced Cancer

                                                                                                      GMP

                                                                                                      Contact Us

 

                                                                                                                                                                                                      © 2019 Baylx,Inc. All rights reserved.

Scientific Publications

Our Representative Publications on Stem Cell Research and Clinical Studies

Wang L, et.al. Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy. Stem Cells Int. 2016; 2016:9165267.

Wang L, et.al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013; 22(24):3192-202.

Wang L, et.al. Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case Rep Transplant. 2013; 2013:146347. PMC3603664.

Liu L et.al. Mechano-Responsive Stem Cells to Target Cancer Metastases Through Biophysical Cues. Sci Transl Med. 2017; 26;9(400).

Liao W, et.al. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. 2016; 77:87-97. PMC4684451

 

Liao W, et.al. Direct Conversion of Cord Blood CD34+ cells into Neural Stem cells by OCT4. Stem Cells Transl Med. 2015; 4(7):755-63. PMC4479625

 

Liu L, et.al. Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay. Stem Cell Res Ther. 2015; 6:181.

 

Vu Q, et.al. Meta-Analysis of Preclinical Studies of Mesenchymal Stromal Cells for Ischemic Stroke. Neurology. 2014; 10, 1212.

 

Eckert MA, et.al. Evidence for High Translational Potential of Mesenchymal Stromal Cell Therapy to Improve Recovery from Ischemic Stroke. J Cereb Blood Flow  Metabo. 2013; 33, 1322-1334. PMC3764389

 

Liu G, et.al. Umbilical cord-derived mesenchymal stem cells regulate thymic epithelial cell development and function in Foxn1(-/-) mice. Cell Mol Immunol. 2014; 11(3):275-84. PMC4085488

 

LiuG, et al. Secreted galectin3 as a biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stem cells. Cytotherapy, 2013; 15(10); 1208-17.

 

Chang PY, et.al. Mesenchymal stem cells can delay radiation-induced crypt death: impact on intestinal CD44+ fragments. Cell and tissue research. 2016; 364 (2), 331-344.

Liao W, et. al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell Physiol Biochem. 2009; 24(3-4):307-16. 

 

Liao W, et.al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation. 2009; 87(3):350- 9.

 

Lu LL et.al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006; 91(8):1017-26.